ReviewMolecular psychiatry2026
Iron dyshomeostasis and its neurobiological mechanisms in psychiatric disorders.
Review in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Brain iron homeostasis is indispensable for sustaining central nervous system development, neural circuit stability, and core neurobiological processes including neurotransmission, mitochondrial energetics, and synaptic plasticity. Compelling clinical and preclinical evidence has established that iron dyshomeostasis represents a pervasive, convergent pathological driver of multiple psychiatric disorders, spanning anxiety, depression, schizophrenia, and neurodevelopmental and affective spectrum conditions. Nevertheless, current literature remains fragmented by disease-specific investigation, with persistent unresolved contradictions regarding regional iron deficiency versus overload in disease pathogenesis. Moreover, the cell-type- and circuit-specific mechanisms linking iron imbalance to psychiatric phenotypes, lacks systematic integration-hindering mechanistic consensus and translational advancement. In this comprehensive review, we synthesize multimodal evidence from human neuroimaging, post-mortem tissue analysis, clinical cohorts, and preclinical animal studies to delineate the distinct regulatory logics governing peripheral and cerebral iron metabolism. We systematically dissect how disrupted iron homeostasis triggers a cascade of neurobiological impairments, encompassing oxidative stress, ferroptosis, neuroinflammation, myelination defects, neurotransmitter dysfunction, and maladaptive synaptic remodeling. Synthesizing these findings, we construct a unified mechanistic framework illustrating how diverse etiological factors-genetic predisposition, chronic psychosocial stress, neuroinflammatory insult, and developmental influences-converge to drive region- and cell-specific iron perturbations and subsequent circuit dysfunction. We further summarize the translational potential and inherent limitations of existing iron-targeted intervention strategies. Collectively, this synthesis positions brain iron dyshomeostasis as a core convergent node in the pathophysiological network of psychiatric disorders, bridges basic iron neurobiology with translational neuroscience, and provides a conceptual framework and practical roadmap for biomarker discovery, mechanistic dissection, and next-generation therapeutic development in psychiatry.
Identifiers
42668270What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.